GlassScriptPhysician profile
Shenggao Han
NPI 1679558746
$18,394.47
in general payments reported to CMS, 2019-2025
62 companies · $2,646 in 2025
The $2,646 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,566 · 2020: $1,700 · 2021: $2,526 · 2022: $2,599 · 2023: $2,769 · 2024: $3,588 · 2025: $2,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,983 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,982.96 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,868.86 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,537.80 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $1,216.85 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $1,072.99 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $948.02 | 2019-2025 | |
| Lilly USA, LLC | $873.70 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $729.17 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $627.21 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Astellas Pharma US INC | $579.94 | 2019-2024 | Veozah, Myrbetriq |
| Phathom Pharmaceuticals, INC. | $559.17 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $536.04 | 2019-2022 | |
| Abbott Laboratories | $478.51 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Daiichi Sankyo INC. | $456.81 | 2019-2025 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $447.12 | 2019-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $423.21 | 2019-2024 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.39 | 2019-2024 | Otezla, Repatha, Prolia |
| Teva Pharmaceuticals USA, INC. | $340.95 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $295.02 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $291.14 | 2023-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $275.62 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $242.09 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Dexcom, INC. | $214.52 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Lundbeck LLC | $212.98 | 2022-2025 | Rexulti |
| Allergan, INC. | $204.34 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $184.91 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $179.03 | 2019-2025 | Trintellix |
| Alkermes, INC. | $169.43 | 2022-2025 | Vivitrol, Vivitrol |
| Verona Pharma, INC. | $138.35 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $133.04 | 2024-2025 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $131.75 | 2021 | |
| Boston Scientific Corporation | $128.60 | 2023-2024 | Watchman Flx, Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $128.44 | 2021-2025 | |
| Electromed, INC. | $125.63 | 2022-2025 | Smartvest |
| Biohaven Pharmaceutical Holding Company LTD. | $121.96 | 2022 | |
| Indivior INC. | $103.29 | 2021-2024 | Sublocade |
| Medtronic, INC. | $88.59 | 2025 | Inceptiv |
| E.R. Squibb & Sons, L.L.C. | $82.07 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $71.77 | 2020-2023 | |
| Vivus LLC | $69.02 | 2025 | Qsymia |
| Antares Pharma, INC. | $65.90 | 2024-2025 | Xyosted |
| Biogen, INC. | $61.43 | 2020-2025 | Spinraza |
| Paratek Pharmaceuticals, INC. | $51.82 | 2019-2025 | Nuzyra |
| Vanda Pharmaceuticals INC. | $48.38 | 2024-2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $41.27 | 2023-2025 | Nuedexta, Rexulti |
| Seqirus USA INC | $36.00 | 2019-2025 | Fluad, Flucelvax |
| Ironwood Pharmaceuticals, INC | $35.55 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $34.88 | 2023 | Arcalyst |
| Idorsia Pharmaceuticals US INC | $34.44 | 2023 | Quviviq |
| Shield Therapeutics INC | $32.02 | 2023-2024 | Accrufer |
| Ardelyx, INC. | $28.42 | 2024 | Ibsrela |
| Sunovion Pharmaceuticals INC. | $26.36 | 2022 | |
| Ucb, INC. | $25.41 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.73 | 2019-2020 | |
| Esperion Therapeutics, INC. | $23.87 | 2020 | |
| Avanir Pharmaceuticals, INC. | $23.64 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $23.23 | 2024 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $18.39 | 2025 | Azmiro |
| Medicomp INC | $15.66 | 2025 | Telepatch Cardiac Monitor |
| Insulet Corporation | $14.81 | 2021 | |
| Assertio Therapeutics, INC. | $14.69 | 2019 | |
| Biodelivery Sciences International, INC. | $13.84 | 2021 | |
| Alfasigma USA, INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shenggao Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.